EDWARDS LIFESCIENCES CORP (EWL.DE) Stock Fundamental Analysis
Europe - FRA:EWL - US28176E1082 - Common Stock
73.99 EUR
+0.54 (+0.74%)
Overall EWL gets a fundamental rating of 7 out of 10. We evaluated EWL against 60 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making EWL a very profitable company, without any liquidiy or solvency issues. EWL is quite expensive at the moment. It does show a decent growth rate. These ratings could make EWL a good candidate for quality investing.
1. Profitability
1.1 Basic Checks
EWL had positive earnings in the past year.
In the past year EWL had a positive cash flow from operations.
EWL had positive earnings in each of the past 5 years.
In the past 5 years EWL always reported a positive cash flow from operatings.
1.2 Ratios
EWL's Return On Assets of 30.75% is amongst the best of the industry. EWL outperforms 100.00% of its industry peers.
EWL has a Return On Equity of 39.33%. This is amongst the best in the industry. EWL outperforms 98.33% of its industry peers.
With a decent Return On Invested Capital value of 9.25%, EWL is doing good in the industry, outperforming 80.00% of the companies in the same industry.
EWL had an Average Return On Invested Capital over the past 3 years of 12.44%. This is above the industry average of 8.99%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 30.75% | ||
| ROE | 39.33% | ||
| ROIC | 9.25% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
1.3 Margins
With an excellent Profit Margin value of 72.96%, EWL belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
EWL's Profit Margin has improved in the last couple of years.
EWL has a Operating Margin of 27.94%. This is amongst the best in the industry. EWL outperforms 98.33% of its industry peers.
In the last couple of years the Operating Margin of EWL has remained more or less at the same level.
EWL's Gross Margin of 78.87% is amongst the best of the industry. EWL outperforms 93.33% of its industry peers.
In the last couple of years the Gross Margin of EWL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.94% | ||
| PM (TTM) | 72.96% | ||
| GM | 78.87% |
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), EWL is creating some value.
EWL has less shares outstanding than it did 1 year ago.
The number of shares outstanding for EWL has been reduced compared to 5 years ago.
The debt/assets ratio for EWL has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 12.96 indicates that EWL is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 12.96, EWL belongs to the top of the industry, outperforming 96.67% of the companies in the same industry.
EWL has a debt to FCF ratio of 1.03. This is a very positive value and a sign of high solvency as it would only need 1.03 years to pay back of all of its debts.
EWL has a Debt to FCF ratio of 1.03. This is amongst the best in the industry. EWL outperforms 86.67% of its industry peers.
A Debt/Equity ratio of 0.06 indicates that EWL is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.06, EWL belongs to the top of the industry, outperforming 85.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 1.03 | ||
| Altman-Z | 12.96 |
ROIC/WACC1.07
WACC8.68%
2.3 Liquidity
A Current Ratio of 4.68 indicates that EWL has no problem at all paying its short term obligations.
EWL has a Current ratio of 4.68. This is amongst the best in the industry. EWL outperforms 95.00% of its industry peers.
EWL has a Quick Ratio of 3.87. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of EWL (3.87) is better than 95.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.68 | ||
| Quick Ratio | 3.87 |
3. Growth
3.1 Past
EWL shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.75%.
The Earnings Per Share has been growing slightly by 7.13% on average over the past years.
EWL shows a small growth in Revenue. In the last year, the Revenue has grown by 4.67%.
Measured over the past years, EWL shows a small growth in Revenue. The Revenue has been growing by 4.58% on average per year.
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%
3.2 Future
The Earnings Per Share is expected to grow by 9.50% on average over the next years. This is quite good.
Based on estimates for the next years, EWL will show a quite strong growth in Revenue. The Revenue will grow by 8.55% on average per year.
EPS Next Y0.42%
EPS Next 2Y5.67%
EPS Next 3Y7.57%
EPS Next 5Y9.5%
Revenue Next Year4.33%
Revenue Next 2Y7.03%
Revenue Next 3Y7.98%
Revenue Next 5Y8.55%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 33.33, EWL can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as EWL.
EWL's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.34.
EWL is valuated quite expensively with a Price/Forward Earnings ratio of 29.28.
The rest of the industry has a similar Price/Forward Earnings ratio as EWL.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.43, EWL is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.33 | ||
| Fwd PE | 29.28 |
4.2 Price Multiples
60.00% of the companies in the same industry are cheaper than EWL, based on the Enterprise Value to EBITDA ratio.
EWL's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 87.01 | ||
| EV/EBITDA | 26.45 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates EWL does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of EWL may justify a higher PE ratio.
PEG (NY)78.64
PEG (5Y)4.67
EPS Next 2Y5.67%
EPS Next 3Y7.57%
5. Dividend
5.1 Amount
EWL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:EWL (11/12/2025, 7:00:00 PM)
73.99
+0.54 (+0.74%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners88.08%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap43.44B
Revenue(TTM)5.88B
Net Income(TTM)4.15B
Analysts77.67
Price Target76.58 (3.5%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.25%
Min EPS beat(2)4.11%
Max EPS beat(2)4.4%
EPS beat(4)4
Avg EPS beat(4)3.37%
Min EPS beat(4)1.57%
Max EPS beat(4)4.4%
EPS beat(8)4
Avg EPS beat(8)0.66%
EPS beat(12)5
Avg EPS beat(12)0.01%
EPS beat(16)6
Avg EPS beat(16)-0.9%
Revenue beat(2)0
Avg Revenue beat(2)-1.11%
Min Revenue beat(2)-2.1%
Max Revenue beat(2)-0.12%
Revenue beat(4)0
Avg Revenue beat(4)-4.22%
Min Revenue beat(4)-13.79%
Max Revenue beat(4)-0.12%
Revenue beat(8)0
Avg Revenue beat(8)-3.15%
Revenue beat(12)1
Avg Revenue beat(12)-2.51%
Revenue beat(16)1
Avg Revenue beat(16)-2.76%
PT rev (1m)-0.07%
PT rev (3m)0.25%
EPS NQ rev (1m)0.67%
EPS NQ rev (3m)0.9%
EPS NY rev (1m)2.21%
EPS NY rev (3m)2.92%
Revenue NQ rev (1m)0.13%
Revenue NQ rev (3m)0.06%
Revenue NY rev (1m)0.65%
Revenue NY rev (3m)0.88%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.33 | ||
| Fwd PE | 29.28 | ||
| P/S | 8.85 | ||
| P/FCF | 87.01 | ||
| P/OCF | 63.26 | ||
| P/B | 4.77 | ||
| P/tB | 6.62 | ||
| EV/EBITDA | 26.45 |
EPS(TTM)2.22
EY3%
EPS(NY)2.53
Fwd EY3.42%
FCF(TTM)0.85
FCFY1.15%
OCF(TTM)1.17
OCFY1.58%
SpS8.37
BVpS15.52
TBVpS11.18
PEG (NY)78.64
PEG (5Y)4.67
Graham Number27.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 30.75% | ||
| ROE | 39.33% | ||
| ROCE | 13.14% | ||
| ROIC | 9.25% | ||
| ROICexc | 13.94% | ||
| ROICexgc | 22.05% | ||
| OM | 27.94% | ||
| PM (TTM) | 72.96% | ||
| GM | 78.87% | ||
| FCFM | 10.17% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
ROICexc(3y)16.13%
ROICexc(5y)17.4%
ROICexgc(3y)22.87%
ROICexgc(5y)24.4%
ROCE(3y)17.66%
ROCE(5y)19.29%
ROICexgc growth 3Y-5.47%
ROICexgc growth 5Y-8.01%
ROICexc growth 3Y-11.82%
ROICexc growth 5Y-8.6%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
F-Score7
Asset Turnover0.42
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 1.03 | ||
| Debt/EBITDA | 0.34 | ||
| Cap/Depr | 142.95% | ||
| Cap/Sales | 3.82% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 45.68% | ||
| Profit Quality | 13.93% | ||
| Current Ratio | 4.68 | ||
| Quick Ratio | 3.87 | ||
| Altman-Z | 12.96 |
F-Score7
WACC8.68%
ROIC/WACC1.07
Cap/Depr(3y)185.14%
Cap/Depr(5y)236.01%
Cap/Sales(3y)5.48%
Cap/Sales(5y)6.41%
Profit Quality(3y)37.92%
Profit Quality(5y)57.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
EPS Next Y0.42%
EPS Next 2Y5.67%
EPS Next 3Y7.57%
EPS Next 5Y9.5%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%
Revenue Next Year4.33%
Revenue Next 2Y7.03%
Revenue Next 3Y7.98%
Revenue Next 5Y8.55%
EBIT growth 1Y0.21%
EBIT growth 3Y-4.72%
EBIT growth 5Y3.49%
EBIT Next Year10.47%
EBIT Next 3Y11.73%
EBIT Next 5Y12.76%
FCF growth 1Y-15.26%
FCF growth 3Y-42.99%
FCF growth 5Y-22.01%
OCF growth 1Y-15.47%
OCF growth 3Y-32.1%
OCF growth 5Y-14.39%
EDWARDS LIFESCIENCES CORP / EWL.DE FAQ
Can you provide the ChartMill fundamental rating for EDWARDS LIFESCIENCES CORP?
ChartMill assigns a fundamental rating of 7 / 10 to EWL.DE.
Can you provide the valuation status for EDWARDS LIFESCIENCES CORP?
ChartMill assigns a valuation rating of 2 / 10 to EDWARDS LIFESCIENCES CORP (EWL.DE). This can be considered as Overvalued.
What is the profitability of EWL stock?
EDWARDS LIFESCIENCES CORP (EWL.DE) has a profitability rating of 8 / 10.
What is the valuation of EDWARDS LIFESCIENCES CORP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for EDWARDS LIFESCIENCES CORP (EWL.DE) is 33.33 and the Price/Book (PB) ratio is 4.77.
How financially healthy is EDWARDS LIFESCIENCES CORP?
The financial health rating of EDWARDS LIFESCIENCES CORP (EWL.DE) is 10 / 10.